Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor (CHEBI:52425)
Annotations: Rat: (18) Mouse: (18) Human: (18) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0)
Parent Terms Term With Siblings Child Terms
1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine 
5-iodo-2'-deoxyuridine  
abacavir +   
acyclovir  
adefovir +   
adefovir pivoxil  
amantadine  
amantadine sulfate 
amprenavir  
aphidicolin  
atazanavir +   
boceprevir 
castanospermine 
cidofovir anhydrous +   
cidofovir dihydrate 
costunolide +   
daclatasvir 
daclatasvir hydrochloride 
darunavir +  
dasabuvir 
dasabuvir sodium +  
dasabuvir sodium hydrate +  
delavirdine +   
delavirdine mesylate 
Descovy 
didanosine  
EC 3.2.1.1 (alpha-amylase) inhibitor +   
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor +   
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor +  
EC 3.2.1.166 (heparanase) inhibitor +  
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor +   
An antiviral drug targeted at influenza viruses. Its mode of action consists of blocking the function of the viral neuraminidase protein (EC 3.2.1.18), thus preventing the virus from budding from the host cell.
EC 3.2.1.20 (alpha-glucosidase) inhibitor +   
EC 3.2.1.23 (beta-galactosidase) inhibitor +  
EC 3.2.1.31 (beta-glucuronidase) inhibitor +  
EC 3.2.1.45 (glucosylceramidase) inhibitor +   
EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor +   
efavirenz  
elbasvir +  
emivirine 
emtricitabine +   
entecavir (anhydrous) +  
entecavir hydrate 
Epclusa 
famciclovir 
floxuridine  
ganciclovir +   
gemcitabine +   
gemcitabine hydrochloride 
Genvoya 
grazoprevir +  
Harvoni 
HIV fusion inhibitor +   
Kaletra 
lamivudine  
ledipasvir +  
lopinavir +   
maraviroc  
N-acetyl-L-cysteinate 
N-acetyl-L-cysteine +   
nevirapine +   
Odefsey 
ombitasvir +  
oseltamivir +   
oseltamivir acid 
paritaprevir +  
penciclovir 
peramivir 
peramivir hydrate +  
phosphonoformic acid +   
Prezcobix 
raltegravir 
ritonavir +   
saquinavir  
seliciclib 
sofosbuvir +  
Technivie 
telaprevir  
telbivudine 
tenofovir (anhydrous) +   
tenofovir alafenamide 
tenofovir alafenamide fumarate +  
tenofovir disoproxil +   
tenofovir disoproxil fumarate  
tenofovir hydrate 
tenofovir(1-) 
tipranavir  
trifluridine +   
trisodium phosphonoformate +  
trisodium phosphonoformate hexahydrate 
valacyclovir 
valganciclovir 
velpatasvir +  
Viekira Pak 
zalcitabine  
Zepatier 
zidovudine  

Synonyms
Related Synonyms: EC 3.2.1.18 inhibitor ;   EC 3.2.1.18 inhibitors ;   N-acylneuraminate glycohydrolase inhibitor ;   N-acylneuraminate glycohydrolase inhibitors ;   Neuraminidase inhibitors ;   acetylneuraminidase inhibitor ;   acetylneuraminidase inhibitors ;   acetylneuraminyl hydrolase inhibitor ;   acetylneuraminyl hydrolase inhibitors ;   alpha-neuraminidase inhibitor ;   alpha-neuraminidase inhibitors ;   exo-alpha-sialidase (EC 3.2.1.18) inhibitors ;   exo-alpha-sialidase inhibitor ;   exo-alpha-sialidase inhibitors ;   neuraminidase inhibitor ;   sialidase inhibitor ;   sialidase inhibitors

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.